mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.7 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |